WilfredoBlasiniMD
Pathology • Fort Myers, FLHematopathology, Anatomic Pathology, Clinical Pathology
Physician
Are you Dr. Blasini?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12751 Westlinks Dr
Unit 3
Fort Myers, FL 33913Phone+1 239-561-9622Fax+1 239-768-5297
Summary
- Dr. Wilfredo Blasini, MD is a board certified pathologist in Fort Myers, Florida. He is currently licensed to practice medicine in Florida, Alaska, and District of Columbia.
Education & Training
University of Puerto Rico School of MedicineClass of 2005
Certifications & Licensure
MI State Medical License 2019 - 2026
CA State Medical License 2018 - 2026
FL State Medical License 2008 - 2026
IL State Medical License 2018 - 2026
TX State Medical License 2019 - 2025
SC State Medical License 2019 - 2025
OH State Medical License 2018 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Hematopathology
- Join now to see all
Publications & Presentations
PubMed
- 69 citationsEfficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.Kristopher A. Sarosiek, Lucas E. Cavallin, Shruti Bhatt, Ngoc L. Toomey, Yasodha Natkunam
Proceedings of the National Academy of Sciences of the United States of America. 2010-07-20 - 8 citationsAcute hemorrhagic edema of infancy: a case report.Wilfredo Blasini, Ritu Saini, Vladimir Vincek
Dermatology Online Journal. 2007-07-13 - 8 citationsPapillary Eccrine Adenoma in Association with Cutaneous HornWilfredo Blasini, Shasa Hu, Dijana Gugic, Vladimir Vincek
American Journal of Clinical Dermatology. 2007-01-01
Press Mentions
Florida Cancer Specialists & Research Institute Celebrates Addition of Next-Generation Genomic Testing Capabilities to Advance Precision Oncology Approach to Patient CareSeptember 6th, 2022
